The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...
GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback